Investigational Drug Information for ALXN1840
What is the drug development status for ALXN1840?
ALXN1840 is an investigational drug.
There have been 14 clinical trials for ALXN1840.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 6th 2021.
The most common disease conditions in clinical trials are Hepatolenticular Degeneration and [disabled in preview]. The leading clinical trial sponsors are Alexion Pharmaceuticals, Wilson Therapeutics AB, and ERT: Clinical Trial Technology Solutions.
There are six US patents protecting this investigational drug and thirty-two international patents.
Summary for ALXN1840
| US Patents | 6 |
| International Patents | 32 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 15 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2021-10-06) |
| Vendors | 26 |
Recent Clinical Trials for ALXN1840
| Title | Sponsor | Phase |
|---|---|---|
| Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease | Alexion Pharmaceuticals | Phase 3 |
| Bioavailability Study of 2 Oral Formulations of ALXN1840 | Alexion Pharmaceuticals | Phase 1 |
| Copper Concentration and Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840 | Alexion Pharmaceuticals | Phase 2 |
Clinical Trial Summary for ALXN1840
Top disease conditions for ALXN1840
Top clinical trial sponsors for ALXN1840
US Patents for ALXN1840
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ALXN1840 | ⤷ Start Trial | Bis-choline tetrathiomolybdate for treating Wilson disease | Alexion Pharmaceuticals Inc | ⤷ Start Trial |
| ALXN1840 | ⤷ Start Trial | Thiomolybdate analogues and uses thereof | Alexion Pharmaceuticals Inc , University of Michigan Ann Arbor | ⤷ Start Trial |
| ALXN1840 | ⤷ Start Trial | Shale inhibition additive for oil/gas down hole fluids and methods for making and using same | Weatherford Technology Holdings LLC | ⤷ Start Trial |
| ALXN1840 | ⤷ Start Trial | Shale inhibition additive for oil/gas down hole fluids and methods for making and using same | Weatherford Technology Holdings LLC | ⤷ Start Trial |
| ALXN1840 | ⤷ Start Trial | Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using same | Weatherford Technology Holdings LLC | ⤷ Start Trial |
| ALXN1840 | ⤷ Start Trial | Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using same | Weatherford Technology Holdings LLC | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ALXN1840
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ALXN1840 | Australia | AU2003256704 | 2022-07-23 | ⤷ Start Trial |
| ALXN1840 | Brazil | BR0312851 | 2022-07-23 | ⤷ Start Trial |
| ALXN1840 | Canada | CA2493127 | 2022-07-23 | ⤷ Start Trial |
| ALXN1840 | China | CN100531732 | 2022-07-23 | ⤷ Start Trial |
| ALXN1840 | China | CN1684678 | 2022-07-23 | ⤷ Start Trial |
| ALXN1840 | Cyprus | CY1114870 | 2022-07-23 | ⤷ Start Trial |
| ALXN1840 | Denmark | DK1556029 | 2022-07-23 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
